Calendar Indivior PLC

Equities

INDV

GB00BN4HT335

Real-time Estimate Cboe Europe 08:04:06 2024-07-15 am EDT 5-day change 1st Jan Change
788.2 GBX -3.22% Intraday chart for Indivior PLC -33.10% -33.33%

Chart calendar Indivior PLC

b5495b8c47e451b283a47f9344482fb.XtQLbwW_A1JNIbXYbWN7KHysLAxgUb7xgY12DHrAUzQ.LPk9ID3JZGQoVYCdIlI8ECjnRFMDENi11_9DZxCiPVMWk04DTop2BRRs3g~e349abed8a19352306aee6c9609a5bde

Upcoming events on Indivior PLC

2024-07-25 02:00 am Q2 2024 Earnings Release
2024-07-25 08:00 am Q2 2024 Earnings Call
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-07-23 Q2 2025 Earnings Release (Projected)

Past events on Indivior PLC

2024-07-09 08:00 am Business Update Call
2024-06-05 08:30 am Jefferies Global Healthcare Conference
2024-05-28 Craig Hallum Institutional Investor Conference
2024-05-23 07:00 am Shareholders Meeting
2024-05-09 07:00 am Annual General Meeting
2024-04-25 08:00 am Q1 2024 Earnings Call
2024-04-25 02:00 am Q1 2024 Earnings Release
2024-02-22 08:00 am Q4 2023 Earnings Call
2024-02-22 02:00 am Q4 2023 Earnings Release
2023-11-28 08:30 am Piper Sandler Healthcare Conference
2023-11-21 09:00 am Jefferies Investor Conference - Fireside Chat
2023-11-14 08:00 am Stifel Healthcare Conference
2023-11-09 08:00 am Q3 2023 Earnings Call
2023-11-09 02:00 am Q3 2023 Earnings Release
2023-09-22 09:00 am Jefferies Global Healthcare Conference
2023-09-11 10:40 am Morgan Stanley Global Healthcare Conference
2023-07-27 08:00 am Q2 2023 Earnings Call
2023-07-27 02:00 am Q2 2023 Earnings Release
2023-06-28 Stifel European Healthcare Summit
2023-06-21 04:00 pm College on Problems of Drug Dependence Scientific Meeting - Poster No: W41

Past dividends on Indivior PLC

2016-06-15 Final Payment 0.073 GBP
2015-09-16 Interim Payment 0.0208 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
785
802
-2.12%
647
648
-0.08%
791
758
4.38%
901
899
0.25%
1 093
1 077
1.45%

1 182

EBITDA
Million USD
Released
Forecast
Spread
222
239
-6.93%
106
113
-6.47%
202
181
11.64%
225
234
-3.74%
288
273
5.57%

340

EBIT
Million USD
Released
Forecast
Spread
202
223
-9.46%
88,0
91,2
-3.51%
187
159
17.44%
212
215
-1.32%
269
249
7.86%

301

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
180
193
-6.74%
-173
-170
-1.76%
190
137
38.69%
-95,0
202
-147.15%
1,00
88,3
-98.87%

201

Net income
Million USD
Released
Forecast
Spread
134
178
-24.72%
-148
-105
-40.48%
205
159
28.61%
-53,0
165
-132.15%
2,00
34,6
-94.22%

145

EPS
USD
Released
Forecast
Spread
0,90
1,17
-23.25%
-1,00
-0,79
-25.89%
1,35
1,00
35%
-0,38
1,13
-133.73%
0,01
0,24
-95.79%

1,11

Announcement Date13/02/2018/02/2116/02/2216/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread



221
219
0.91%
253
243
4.12%
276
255
8.24%
271
271
0.18%
293
276
6.16%
284
300
-5.25%

296


290


301


308


316

EBITDA
Million USD
Released
Forecast
Spread


















77,0
87,1
-11.6%















EBIT
Million USD
Released
Forecast
Spread






71,0
59,0
20.34%
71,0
46,0
54.35%
60,0
60,5
-0.83%
66,0
52,0
26.92%
70,0
74,1
-5.47%

67,7


73,1


81,9


83,4


82,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread









62,0
40,0
55%
-181
57,0
-417.54%
61,0
52,0
17.31%
63,0
73,7
-14.46%

27,3


32,7


78,0


77,8


77,0

Net income
Million USD
Released
Forecast
Spread
41,0





44,0


39,0
32,0
21.88%
-135
43,0
-413.95%
54,0
41,5
30.12%
47,0
58,2
-19.24%

19,8


24,7


60,8


59,9


59,3

EPS
USD
Released
Forecast
Spread
0,30





0,31



0,22

-0,98
0,30
-426.67%
0,38
0,28
35.71%
0,34
0,42
-18.07%

0,15


0,18


0,45


0,45


0,45

Announcement Date28/04/2228/07/2227/04/2327/07/2309/11/2322/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise